Crestchem [CRSTCHM] vs Kingfa Science [KINGFA] Detailed Stock Comparison
Crestchem
BSE
Loading...
Kingfa Science
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Crestchem wins in 10 metrics, Kingfa Science wins in 8 metrics, with 0 ties. Crestchem appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Crestchem | Kingfa Science | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.74 | 30.12 | Crestchem |
| Price-to-Book Ratio | 5.01 | 6.35 | Crestchem |
| Debt-to-Equity Ratio | 0.00 | 5.90 | Crestchem |
| PEG Ratio | N/A | 16.19 | N/A |
| EV/EBITDA | 0.00 | 20.76 | Crestchem |
| Profit Margin (TTM) | 9.94% | 8.58% | Crestchem |
| Operating Margin (TTM) | 9.13% | 11.17% | Kingfa Science |
| EBITDA Margin (TTM) | 9.13% | 11.17% | Kingfa Science |
| Return on Equity | 36.47% | 20.98% | Crestchem |
| Return on Assets (TTM) | 25.86% | 13.23% | Crestchem |
| Free Cash Flow (TTM) | $15.21M | $295.94M | Kingfa Science |
| Dividend Yield | 1.14% | 0.32% | Crestchem |
| 1-Year Return | -25.66% | 31.52% | Kingfa Science |
| Price-to-Sales Ratio (TTM) | 1.50 | 2.58 | Crestchem |
| Enterprise Value | $0 | $46.42B | Kingfa Science |
| EV/Revenue Ratio | 0.00 | 2.59 | Crestchem |
| Gross Profit Margin (TTM) | 20.25% | 22.30% | Kingfa Science |
| Revenue per Share (TTM) | $83 | $1,478 | Kingfa Science |
| Earnings per Share (Diluted) | $9.08 | $126.75 | Kingfa Science |
| Beta (Stock Volatility) | N/A | 0.66 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Crestchem vs Kingfa Science Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Crestchem | -1.08% | -18.36% | -26.70% | -40.12% | -40.40% | -57.58% |
| Kingfa Science | 8.58% | 9.13% | 12.07% | 18.51% | 37.66% | 11.62% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Crestchem | -25.66% | -25.66% | -25.66% | -25.66% | -25.66% | -25.66% |
| Kingfa Science | 31.52% | 278.86% | 672.29% | 1,316.36% | 10,861.24% | 12,694.24% |
Performance & Financial Health Analysis: Crestchem vs Kingfa Science
| Metric | CRSTCHM | KINGFA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹374.25M | ₹46.24B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,917 | 17,014 |
| 90 Day Avg. Volume | 1,625 | 14,157 |
| Last Close | ₹123.40 | ₹4,145.30 |
| 52 Week Range | ₹119.95 - ₹350.00 | ₹2,550.00 - ₹4,190.00 |
| % from 52W High | -64.74% | -1.07% |
| All-Time High | ₹193.00 (Jun 16, 2025) | ₹4,190.00 (Aug 18, 2025) |
| % from All-Time High | -36.06% | -1.07% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.11% |
| Quarterly Earnings Growth | -0.42% | 0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.09% |
| Operating Margin (TTM) | 0.09% | 0.11% |
| Return on Equity (TTM) | 0.36% | 0.21% |
| Debt to Equity (MRQ) | 0.00 | 5.90 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹24.92 | ₹601.64 |
| Cash per Share (MRQ) | N/A | ₹19.54 |
| Operating Cash Flow (TTM) | ₹17.84M | ₹993.76M |
| Levered Free Cash Flow (TTM) | ₹27.27M | ₹1.53B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.14% | 0.32% |
| Last 12-Month Dividend | ₹1.50 | ₹10.00 |
Valuation & Enterprise Metrics Analysis: Crestchem vs Kingfa Science
| Metric | CRSTCHM | KINGFA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.74 | 30.12 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | 16.19 |
| Price to Sales (TTM) | 1.50 | 2.58 |
| Price to Book (MRQ) | 5.01 | 6.35 |
| Market Capitalization | ||
| Market Capitalization | ₹374.25M | ₹46.24B |
| Enterprise Value | ₹0 | ₹46.42B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.00 | 2.59 |
| Enterprise to EBITDA | 0.00 | 20.76 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.66 |
| Book Value per Share (MRQ) | ₹24.92 | ₹601.64 |
Financial Statements Comparison: Crestchem vs Kingfa Science
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CRSTCHM | KINGFA |
|---|---|---|
| Revenue/Sales | ₹72.32M | ₹4.70B |
| Cost of Goods Sold | ₹57.68M | ₹3.63B |
| Gross Profit | ₹14.65M | ₹1.07B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹5.86M | ₹905.70M |
| EBITDA | ₹7.43M | ₹623.82M |
| Pre-Tax Income | ₹7.26M | ₹543.29M |
| Income Tax | ₹1.16M | ₹124.31M |
| Net Income (Profit) | ₹6.10M | ₹418.98M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CRSTCHM | KINGFA |
|---|---|---|
| Cash & Equivalents | ₹7.32M | ₹234.80M |
| Total Current Assets | ₹43.06M | ₹8.54B |
| Total Current Liabilities | ₹29.97M | ₹4.22B |
| Long-Term Debt | N/A | ₹20.61M |
| Total Shareholders Equity | ₹74.76M | ₹7.29B |
| Retained Earnings | N/A | ₹4.55B |
| Property, Plant & Equipment | N/A | ₹2.44B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CRSTCHM | KINGFA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CRSTCHM | KINGFA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,917 | 17,014 |
| Average Daily Volume (90 Day) | 1,625 | 14,157 |
| Shares Outstanding | 3.00M | 12.11M |
| Float Shares | 1.98M | 1.66M |
| % Held by Insiders | 0.32% | 0.86% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Crestchem vs Kingfa Science
| Metric | CRSTCHM | KINGFA |
|---|---|---|
| Last 12-Month Dividend | ₹1.50 | ₹10.00 |
| Last 12-Month Dividend Yield | 1.14% | 0.32% |
| 3-Year Avg Annual Dividend | ₹0.50 | ₹3.33 |
| 3-Year Avg Dividend Yield | 0.50% | 0.30% |
| 3-Year Total Dividends | ₹1.50 | ₹10.00 |
| Ex-Dividend Date | Aug 13, 2025 | Sep 17, 2024 |